Cargando…

TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8(+) T Cells in Hepatocellular Carcinoma

BACKGROUND & AIMS: TIGIT is a co-inhibitory receptor, and its suitability as a target for cancer immunotherapy in HCC is unknown. PD1 blockade is clinically effective in about 20% of advanced HCC patients. Here we aim to determine whether co-blockade of TIGIT/PD1 has added value to restore funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Zhouhong, Zhou, Guoying, Campos Carrascosa, Lucia, Gausvik, Erik, Boor, Patrick P.C., Noordam, Lisanne, Doukas, Michael, Polak, Wojciech G., Terkivatan, Türkan, Pan, Qiuwei, Takkenberg, R. Bart, Verheij, Joanne, Erdmann, Joris I., IJzermans, Jan N.M., Peppelenbosch, Maikel P., Kraan, Jaco, Kwekkeboom, Jaap, Sprengers, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255944/ https://www.ncbi.nlm.nih.gov/pubmed/33781741 http://dx.doi.org/10.1016/j.jcmgh.2021.03.003

Ejemplares similares

TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
por: Ge, Zhouhong, et al.
Publicado: (2021)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma
por: Noordam, Lisanne, et al.
Publicado: (2021)

GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
por: van Beek, Adriaan A., et al.
Publicado: (2019)

Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance
por: Liu, Jiaye, et al.
Publicado: (2020)

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients
por: Noordam, Lisanne, et al.
Publicado: (2022)

PD-L1, Galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
por: Sideras, Kostandinos, et al.
Publicado: (2017)

Hepatocellular adenoma: when and how to treat? Update of current evidence
por: Thomeer, Maarten G., et al.
Publicado: (2016)

Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma
por: Ma, Buyun, et al.
Publicado: (2018)

LGR5 marks targetable tumor-initiating cells in mouse liver cancer
por: Cao, Wanlu, et al.
Publicado: (2020)

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells
por: Campos Carrascosa, Lucia, et al.
Publicado: (2020)

Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection
por: Duizendstra, Aafke A., et al.
Publicado: (2022)

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
por: Zhou, Guoying, et al.
Publicado: (2018)

First case report of chylous ascites after robot-assisted donor nephrectomy
por: Janki, Shiromani, et al.
Publicado: (2016)

Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2017)

Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth
por: Li, Meng, et al.
Publicado: (2020)

Camrelizumab—targeting a novel PD-1 epitope to treat hepatocellular carcinoma
por: Rakké, Yannick Sebastiaan, et al.
Publicado: (2020)

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
por: Sideras, Kostandinos, et al.
Publicado: (2019)

Activated CD4(+) T Cells and Highly Differentiated Alloreactive CD4(+) T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients
por: Duizendstra, Aafke A., et al.
Publicado: (2021)

The biological process of lysine‐tRNA charging is therapeutically targetable in liver cancer
por: Zhang, Ruyi, et al.
Publicado: (2020)

Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling()
por: Wang, Wenhui, et al.
Publicado: (2016)

Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
por: Zhou, Guoying, et al.
Publicado: (2022)

Potential association between COVID-19 mortality and health-care resource availability
por: Ji, Yunpeng, et al.
Publicado: (2020)

Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific
por: Xu, Lei, et al.
Publicado: (2014)

GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells
por: Rakké, Yannick S., et al.
Publicado: (2022)

Minimally Invasive Liver Surgery: A Snapshot from a Major Dutch HPB and Transplant Center
por: Marino, Rebecca, et al.
Publicado: (2022)

Errors in translational decoding: tRNA wobbling or misincorporation?
por: Ou, Xumin, et al.
Publicado: (2019)

Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
por: Li, Pengfei, et al.
Publicado: (2021)

Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
por: Wang, Wenshi, et al.
Publicado: (2017)

The Management of Pregnancy in Women with Hepatocellular Adenoma: A Plea for an Individualized Approach
por: Bröker, Mirelle E. E., et al.
Publicado: (2012)

Independent Risk Factors for Urological Complications after Deceased Donor Kidney Transplantation
por: Slagt, Inez K. B., et al.
Publicado: (2014)

Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
por: Kamp, Eline J.C.A., et al.
Publicado: (2021)

Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis
por: Kamp, Eline JCA, et al.
Publicado: (2022)

Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
por: Wang, Wenhui, et al.
Publicado: (2016)

Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
por: Sideras, K, et al.
Publicado: (2015)

Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
por: Hernanda, Pratika Y., et al.
Publicado: (2013)

A novel difficulty grading system for laparoscopic living donor nephrectomy
por: Takagi, Kosei, et al.
Publicado: (2020)

TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020)

Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
por: Qu, Changbo, et al.
Publicado: (2017)

Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections
por: Qu, Changbo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oi7qubpu80ibgpnrhstbift02a